| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |